The clinical characteristics of PD comprise motor disorders, such as static tremor, muscle stiffness, motor retardation, gait disorders and non-motor symptoms, such as reduced sense of smell, mental disorders, sleep disorders, cognitive disorders 3
As a triple agonist , it simultaneously activates three distinct receptor systems [5]: GIP (Glucose-dependent Insulinotropic Polypeptide) receptors enhance insulin secretion and may have direct effects on adipose tissue GLP-1 (Glucagon-like Peptide-1) receptors promote satiety, slow gastric emptying, and improve glucose regulation Glucagon receptors increase energy expenditure and may enhance fat oxidation This multi-receptor targeting strategy distinguishes retatrutide from single-pathway peptides and creates a complex metabolic profile that researchers are still working to fully characterize
Certificate of Analysis & Safety Data Frequently Asked Questions Is L-GLUTATHIONE third-party tested
If you purchased the medication from an unreputable social media ad or an unlicensed website without a doctors consultation, do not use it